Life sciences firm Agilent Technologies will acquire privately held clinical pathology firm Biocare Medical in an all-cash ‌deal valued at $950 million

www.reuters.com

Life sciences firm Agilent Technologies will acquire privately held clinical pathology firm Biocare Medical in an all-cash ‌deal valued at $950 million

www.reuters.com

InnerworldM to

Mergers and Acquisitions (M&A)English · 14 days ago

reuters.com

www.reuters.com

You must log in or # to comment.

Chat

Mergers and Acquisitions (M&A)

Mergers_Acquisitions

Create a post

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: [email protected]

Transactions in which the ownership of companies, other business organizations, or their assets or operating units have been transferred or consolidated.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

6 users / day
11 users / week
25 users / month
83 users / 6 months
15 local subscribers
17 subscribers
231 Posts
14 Comments
Modlog

mods:
Innerworld

Life sciences firm Agilent Technologies will acquire ​privately held clinical pathology firm Biocare Medical in an all-cash ‌deal valued at $950 million

Life sciences firm Agilent Technologies will acquire ​privately held clinical pathology firm Biocare Medical in an all-cash ‌deal valued at $950 million

reuters.com

Life sciences firm Agilent Technologies will acquire privately held clinical pathology firm Biocare Medical in an all-cash ‌deal valued at $950 million

Life sciences firm Agilent Technologies will acquire privately held clinical pathology firm Biocare Medical in an all-cash ‌deal valued at $950 million